Bio-Technopark

In very close proximity to the Swiss Federal Institute of Technology (ETH), the University and Zurich University Hospital, a science park for life science companies and institutions has developed in the last two decades, which has now acquired both national and international significance. On the former site of the Schweizerische Wagons- und Aufzügefabrik AG and on neighboring sites, 100,000 m2 of laboratory, production and office space is now leased to around 60 companies and organizations, and 80 academic research groups. Video

read more

Leasing

In the Bio-Technopark, it is possible to rent ultramodern laboratories, offices, and complex infrastructure for research and development purposes. The premises offered include fully-equipped laboratory facilities with partly shared infrastructure, and individual rental areas in different sizes and locations and with different fit-out standards. The Bio-Technopark is still being developed and gradually fitted out.

read more

Services

The Bio-Technopark promotes the transfer of knowledge and technology, as well as the foundation and building up of life science companies. In addition to advice, coaching, and support for those who are setting up and developing companies and looking for financing, its services include the organization of events that focus on networking, facilitating the exchange of ideas between specialists, and advanced training.

 

read more

News

Fast, Painless, Precise: New Urine Test for Prostate Cancer Screening

Zurich/Schlieren ZH - Researchers at the University of Zurich are developing a urine test for the diagnosis of prostate cancer. To advance the project and organize mass screening, they have founded the spin-off ONTRACK Biomedical. Biochemist Irina Banzola and urologist Daniel Eberli of the University of Zurich (UZH) have developed a...

read more

Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025in

Schlieren (Zurich), Switzerland, April 15, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial performance for the first three months of 2025. Revenue from Direct MagnetOs product sales rose 79% in the first three months of 2025, to USD...

read more

Events

  • Swiss Biotech Day 2025
    05.05.2025
  • Bio-Technopark After Work Networking Aperitif
    06.05.2025
  • LIFE SCIENCE ZURICH IMPACT CONFERENCE
    26.05.2025